TCL Archive Minority Accrual Low In Prevention Trials; NCI Plans Programs To Boost enrollment February 2, 1996
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Leukemia Biology Study Needed To Improve Results, Pinkel Says In Karnfsky Lecture April 7, 1978